Invention Grant
- Patent Title: Anti-tumor immunotherapy
- Patent Title (中): 抗肿瘤免疫治疗
-
Application No.: US12997630Application Date: 2009-06-16
-
Publication No.: US08828403B2Publication Date: 2014-09-09
- Inventor: Gilberto Filaci , Francesco Indiveri , Paolo Traverso
- Applicant: Gilberto Filaci , Francesco Indiveri , Paolo Traverso
- Applicant Address: IT Milan
- Assignee: Mediolanum Farmaceutici S.p.A.
- Current Assignee: Mediolanum Farmaceutici S.p.A.
- Current Assignee Address: IT Milan
- Agency: Lucas & Mercanti, LLP
- International Application: PCT/EP2009/004337 WO 20090616
- International Announcement: WO2010/003520 WO 20100114
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/03 ; A61K39/00 ; A61K45/00 ; A61K47/44 ; A61K38/45 ; C12N9/12 ; C07K14/00
Abstract:
The present invention relates to the use of telomerase-derived peptides for the treatment of any cancer patients, particularly for the treatment of patients with renal or prostate cancer.
Public/Granted literature
- US20110135692A1 ANTI-TUMOR IMMUNOTHERAPY Public/Granted day:2011-06-09
Information query
IPC分类:
